Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.
Latest website image capture
Clouds background image

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing all study sites by state (Alabama, Arizona, California, District of Columbia, Florida, Hawaii, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Texas, Washington) and updated the revision tag from v3.3.2 to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T22:35:09.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The PubMed publications section text was updated to state that entries are auto-filled from PubMed and may not pertain to the study, and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:22:30.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page no longer shows the government funding/NIH operating status notice; other study details and links remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:10:23.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The two screenshots show the Study Details page with no substantive changes to content or structure; only minor UI or rendering differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:10:11.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Major update: version bumped to v3.2.0 and a government funding/operating-status notice added; previous version v3.1.0 removed.
    Difference
    3%
    Check dated 2025-10-06T05:33:46.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Appended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.
    Difference
    0.4%
    Check dated 2025-09-29T03:06:00.000Z thumbnail image

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.